home / stock / sva:cc / sva:cc news


SVA:CC News and Press, Sernova Corp. From 01/29/24

Stock Information

Company Name: Sernova Corp.
Stock Symbol: SVA:CC
Market: TSXVC
Website: sernova.com

Menu

SVA:CC SVA:CC Quote SVA:CC Short SVA:CC News SVA:CC Articles SVA:CC Message Board
Get SVA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

SVA:CC - Sernova Provides Recap of 2023 Accomplishments and Anticipated 2024 Milestones

(TheNewswire) Recently completed recruitment of all 7 patients in Cohort 2 Anticipates additional data from Cohort 2 of Phase 1/2 clinical trial evaluating its enhanced 10-channel Cell Pouch in patients with type 1 diabetes (T1D) in Q1/24 Expects to report precli...

SVA:CC - Expected Canadian Company Earnings on Thursday, January 25th, 2024

Rupert Resources Ltd. (RUP:CA) is expected to report for Q3 2024 Bioasis Technologies Inc. (BTI:CA) is expected to report for quarter end 2023-11-30 Sego Resources Inc. (SGZ:CA) is expected to report for Q2 2024 Encore Energy Corp. (EU:CA) is expected to report for Q4 2023 Silver ...

SVA:CC - Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA

LONDON, Ontario and WINDHAM COUNTY, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) ...

SVA:CC - Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System(TM) at the 2023 IPITA-IXA-CTRMS Joint Congress

LONDON, Ontario and WINDHAM COUNTY, Conn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced an update on its conformal coating immune protection technology program, that is used in co...

SVA:CC - Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System(TM) for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress

All six patients in the first cohort (Cohort A) were successfully implanted with the 8-channel Cell Pouch System with post-transplant follow-up periods ranging from 6 months to 3.5 years; 5 of 6 patients in Cohort A discontinued insulin therapy (insulin independent) following islet transplant...

SVA:CC - Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress

Dr. Piotr Witkowski presenting new data from ongoing Phase 1/2 clinical trial of the Cell Pouch System™ in patients with type 1 diabetes (T1D) Dr. Alice Tomei presenting preclinical data on transplantation of conformal coated islet cells in pre-vascularized Cell Pouch LONDO...

SVA:CC - Sernova Presents Compelling New Data on the Cell Pouch System(TM) as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual Meeting

LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced new preclinical data for its novel cell therapy platform, the Cell Pouch System, as a pote...

SVA:CC - Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22

LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it has rescheduled the investor and analyst conference call previously scheduled for Septe...

SVA:CC - Expected Canadian Company Earnings on Wednesday, September 13th, 2023

Leon's Furniture Limited (LNF:CA) is expected to report for Q2 2023 Dollarama Inc. (DOL:CA) is expected to report $0.77 for Q2 2024 Source Energy Services Ltd. (SHLE:CA) is expected to report for Q1 2024 Orsu Metals Corporation (OSU.H:CA) is expected to report for quarter end 2023-06-...

SVA:CC - Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update

- Introduction of New CEO Cynthia Pussinen and Recently Appointed Chief Business Officer, Dr. Modestus Obochi, on September 15, 2023 - - Business Update, Strategy & Outlook Call on October 5, 2023 - LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Sernov...

Previous 10 Next 10